Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer

被引:0
|
作者
Yuri Kimura
Shinsuke Sasada
Akiko Emi
Norio Masumoto
Takayuki Kadoya
Morihito Okada
机构
[1] Hiroshima University,Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine
来源
Supportive Care in Cancer | 2021年 / 29卷
关键词
Breast cancer; Primary prophylactic G-CSF; Febrile neutropenia; TC chemotherapy; Relative dose intensity; Hospitalization;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3507 / 3512
页数:5
相关论文
共 50 条
  • [31] The cost-effectiveness of primary prophylaxis with granulocyte colony-stimulating factor in docetaxel-containing adjuvant chemotherapy in early breast cancer: The impact of risk of febrile neutropenia and its mortality
    Chan, K. K.
    Trudeau, M. E.
    Eisen, A.
    Verreault, J. L.
    Freedman, C. A.
    Dent, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] Impact of colony-stimulating factors to reduce febrile neutropenic events in breast cancer patients receiving docetaxel plus cyclophosphamide chemotherapy
    Alexandre Chan
    Wing Hang Fu
    Vivianne Shih
    Jurja Chua Coyuco
    Sze Huey Tan
    Raymond Ng
    Supportive Care in Cancer, 2011, 19 : 497 - 504
  • [33] Impact of colony-stimulating factors to reduce febrile neutropenic events in breast cancer patients receiving docetaxel plus cyclophosphamide chemotherapy
    Chan, Alexandre
    Fu, Wing Hang
    Shih, Vivianne
    Coyuco, Jurja Chua
    Tan, Sze Huey
    Ng, Raymond
    SUPPORTIVE CARE IN CANCER, 2011, 19 (04) : 497 - 504
  • [34] Granulocyte colony-stimulating factor in established febrile neutropenia: A randomized study of pediatric patients
    Mitchell, PLR
    Morland, B
    Stevens, MCG
    Dick, G
    Easlea, D
    Meyer, LC
    Pinkerton, CR
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1163 - 1170
  • [35] Clinical practice in febrile neutropenia risk assessment and granulocyte colony-stimulating factor primary prophylaxis of febrile neutropenia in Poland
    Wojtukiewicz, Marek
    Chmielowska, Ewa
    Filipczyk-Cisarz, Emilia
    Krzemieniecki, Krzysztof
    Lesniewski-Kmak, Krzysztof
    Litwiniuk, Maria M.
    Wieruszewska-Kowalczyk, Karolina
    Kosno-Kruszewska, Elzbieta
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2014, 18 (06): : 419 - 424
  • [36] Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia
    Hartmann, LC
    Tschettier, LK
    Habermann, TM
    Ebbert, LP
    Johnson, PS
    Mailliard, JA
    Levitt, R
    Suman, VJ
    Witzig, TE
    Wieand, HS
    Miller, LL
    Moertel, CG
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (25): : 1776 - 1780
  • [37] Prophylactic granulocyte colony-stimulating factor treatment for acquired chronic severe neutropenia in pregnancy
    Sangalli, MR
    Peek, M
    McDonald, A
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2001, 41 (04): : 470 - 471
  • [38] Clinical utilization of long-acting granulocyte colony-stimulating factor (pegfilgrastim) prophylaxis in breast cancer patients with adjuvant docetaxel-cyclophosphamide chemotherapy
    Jeon, Ye Won
    Lim, Seung Taek
    Gwak, Hongki
    Park, Seon Young
    Shin, Juhee
    Han, Hye Sug
    Suh, Young Jin
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2021, 100 (02) : 59 - 66
  • [39] A Bayesian meta-analysis of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in children with cancer
    Sung, L
    Beyene, J
    Hayden, J
    Nathan, PC
    Lange, B
    Tomlinson, GA
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2006, 163 (09) : 811 - 817
  • [40] Granulocyte colony-stimulating factor in afebrile patients with neutropenia
    Cabanillas, F
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (18): : 1319 - 1319